Motley Fool Speculates About Fresenius Purchase of NxStage
Will NxStage stock price volatility affect he sale of NxStage to purchaser Fresenius Medical Care? Time will tell, and revenues are up, but profits are not.
Read the full article » | Posted 06-12-2018
Related Articles
- Nephrologist Dr. Roberto Collazo Shares New Treatments for Kidney Disease and ESKD Posted 12-11-2024
- Ellen Lukens from CMMI Presents on the Kidney Care Choices Model Posted 12-11-2024
- 2025 NKF Survey on Kidney Health Priorities Finds Home Dialysis is a Patient Priority Posted 12-11-2024
- FDA Correction on Baxter MiniCap Extended Life PD Transfer Set Posted 12-11-2024